Edition:
United Kingdom

Cellectis SA (CLLS.OQ)

CLLS.OQ on NASDAQ Stock Exchange Global Market

19.75USD
18 Mar 2019
Change (% chg)

$0.44 (+2.28%)
Prev Close
$19.31
Open
$19.09
Day's High
$19.87
Day's Low
$19.09
Volume
70,330
Avg. Vol
43,713
52-wk High
$38.85
52-wk Low
$15.35

Chart for

About

Cellectis SA is a France-based company active in the field of genome engineering and genomic surgery. The Company specializes in the research, development and commercialization of rational genome engineering technologies. It has developed an expertise in combining meganucleases with engineered targeting Deoxyribonucleic Acid... (more)

Overall

Beta: --
Market Cap(Mil.): $1,013.89
Shares Outstanding(Mil.): 35.42
Dividend: --
Yield (%): --

Financials

  CLLS.OQ Industry Sector
P/E (TTM): -- 69.32 32.54
EPS (TTM): -2.24 -- --
ROI: -27.62 8.89 13.82
ROE: -27.69 10.00 15.25

BRIEF-Cellectis Q4 Operating Loss Widens To 29.3 Million Dollars

* ANNOUNCED ON MONDAY, CELLECTIS REPORTS 4TH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS

12 Mar 2019

BRIEF-Cellectis Reports End-Sept Cash Of 475.9 Million Dollars

* REPORTED ON TUESDAY TOTAL CASH, CASH EQUIVALENTS AND CURRENT FINANCIAL ASSETS $475.9 MILLION AS OF SEPTEMBER 30, 2018

14 Nov 2018

Earnings vs. Estimates